drugset / Trial / NCT06259526
A Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe Depression
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe Depression
Timeline
- Start
- 2023-12-26
- Primary completion
- 2024-10-23
- Completion
- 2024-10-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Duloxetine | Small molecule | — | — |
| Subject | JS1-1-01 | Unknown | 25 mg | — |
| Subject | JS1-1-01 | Unknown | 50 mg | — |
| Subject | JS1-1-01 | Unknown | 75 mg | — |